These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28152638)

  • 1. Are vasopressors useful in toxin-induced cardiogenic shock?
    Skoog CA; Engebretsen KM
    Clin Toxicol (Phila); 2017 Apr; 55(4):285-304. PubMed ID: 28152638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment for calcium channel blocker poisoning: a systematic review.
    St-Onge M; Dubé PA; Gosselin S; Guimont C; Godwin J; Archambault PM; Chauny JM; Frenette AJ; Darveau M; Le Sage N; Poitras J; Provencher J; Juurlink DN; Blais R
    Clin Toxicol (Phila); 2014 Nov; 52(9):926-44. PubMed ID: 25283255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiogenic shock: Inotropes and vasopressors.
    Amado J; Gago P; Santos W; Mimoso J; de Jesus I
    Rev Port Cardiol; 2016 Dec; 35(12):681-695. PubMed ID: 27836218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical care management of verapamil and diltiazem overdose with a focus on vasopressors: a 25-year experience at a single center.
    Levine M; Curry SC; Padilla-Jones A; Ruha AM
    Ann Emerg Med; 2013 Sep; 62(3):252-8. PubMed ID: 23642908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for beta-blocker poisoning: a systematic review.
    Rotella JA; Greene SL; Koutsogiannis Z; Graudins A; Hung Leang Y; Kuan K; Baxter H; Bourke E; Wong A
    Clin Toxicol (Phila); 2020 Oct; 58(10):943-983. PubMed ID: 32310006
    [No Abstract]   [Full Text] [Related]  

  • 6. Inotropes and vasopressors use in cardiogenic shock: when, which and how much?
    Levy B; Buzon J; Kimmoun A
    Curr Opin Crit Care; 2019 Aug; 25(4):384-390. PubMed ID: 31166204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled study comparing high-dose insulin to vasopressors or combination therapy in a porcine model of refractory propranolol-induced cardiogenic shock.
    Katzung KG; Leroy JM; Boley SP; Stellpflug SJ; Holger JS; Engebretsen KM
    Clin Toxicol (Phila); 2019 Nov; 57(11):1073-1079. PubMed ID: 30806099
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-cardiogenic pulmonary edema and life-threatening shock due to calcium channel blocker overdose: a case report and clinical review.
    Siddiqi TA; Hill J; Huckleberry Y; Parthasarathy S
    Respir Care; 2014 Feb; 59(2):e15-21. PubMed ID: 23674813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Clinical Review of Vasopressors in Emergency Medicine.
    Stampfl M; DeBlieux P
    J Emerg Med; 2024 Jul; 67(1):e31-e41. PubMed ID: 38789351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality.
    Tarvasmäki T; Lassus J; Varpula M; Sionis A; Sund R; Køber L; Spinar J; Parissis J; Banaszewski M; Silva Cardoso J; Carubelli V; Di Somma S; Mebazaa A; Harjola VP;
    Crit Care; 2016 Jul; 20(1):208. PubMed ID: 27374027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a Porcine Model to Evaluate the Risks and Benefits of Vasopressors in Propranolol Poisoning.
    Cole JB; Corcoran JN; Engebretsen KM; Stellpflug SJ
    J Med Toxicol; 2020 Apr; 16(2):212-221. PubMed ID: 31981076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inotropic Agents and Vasopressors in the Treatment of Cardiogenic Shock.
    Shabana A; Dholoo F; Banerjee P
    Curr Heart Fail Rep; 2020 Dec; 17(6):438-448. PubMed ID: 33103204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose insulin: a consecutive case series in toxin-induced cardiogenic shock.
    Holger JS; Stellpflug SJ; Cole JB; Harris CR; Engebretsen KM
    Clin Toxicol (Phila); 2011 Aug; 49(7):653-8. PubMed ID: 21819291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of vasopressors and inotropics in cardiogenic shock].
    Lemm H; Dietz S; Janusch M; Buerke M
    Herz; 2017 Feb; 42(1):3-10. PubMed ID: 28101622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State of Shock: Contemporary Vasopressor and Inotrope Use in Cardiogenic Shock.
    Bloom JE; Chan W; Kaye DM; Stub D
    J Am Heart Assoc; 2023 Aug; 12(15):e029787. PubMed ID: 37489740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose intravenous glucagon in severe tricyclic poisoning.
    Sensky PR; Olczak SA
    Postgrad Med J; 1999 Oct; 75(888):611-2. PubMed ID: 10621904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early vasopressor use following traumatic injury: a systematic review.
    Hylands M; Toma A; Beaudoin N; Frenette AJ; D'Aragon F; Belley-Côté É; Charbonney E; Møller MH; Laake JH; Vandvik PO; Siemieniuk RA; Rochwerg B; Lauzier F; Green RS; Ball I; Scales D; Murthy S; Kwong JSW; Guyatt G; Rizoli S; Asfar P; Lamontagne F
    BMJ Open; 2017 Nov; 7(11):e017559. PubMed ID: 29151048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic therapies for acute cardiogenic shock.
    Nativi-Nicolau J; Selzman CH; Fang JC; Stehlik J
    Curr Opin Cardiol; 2014 May; 29(3):250-7. PubMed ID: 24686400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning.
    Engebretsen KM; Kaczmarek KM; Morgan J; Holger JS
    Clin Toxicol (Phila); 2011 Apr; 49(4):277-83. PubMed ID: 21563902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon in beta-blocker and calcium channel blocker overdoses: a systematic review.
    Bailey B
    J Toxicol Clin Toxicol; 2003; 41(5):595-602. PubMed ID: 14514004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.